Tiedemann Advisors, LLC Laboratory Corp Of America Holdings Transaction History

Tiedemann Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$213.86 - $277.87 $335,118 - $435,422	-1,567 Closed	0 $0
Q1 2022 Apr 27, 2022	BUY	$259.82 - $298.18 $3,117 - $3,578	12 Added 0.77%	1,567 $413,000
Q3 2021 Nov 12, 2021	SELL	$274.82 - $308.34 $3,297 - $3,700	-12 Reduced 0.77%	1,555 $438,000
Q2 2021 Aug 12, 2021	SELL	$251.87 - $278.14 $4,785 - $5,284	-19 Reduced 1.2%	1,567 $432,000
Q1 2021 May 13, 2021	BUY	$204.88 - $255.03 $49,376 - $61,462	241 Added 17.92%	1,586 $404,000
Q4 2020 Feb 16, 2021	BUY	$186.91 - $214.42 $11,588 - $13,294	62 Added 4.83%	1,345 $274,000
Q2 2020 Nov 12, 2020	BUY	$113.31 - $182.44 $906 - $1,459	8 Added 0.63%	1,283 $212,000
Q2 2020 Aug 05, 2020	BUY	$113.31 - $182.44 $144,470 - $232,611	1,275 New	1,275 $211,000
Q1 2020 May 07, 2020	SELL	$104.32 - $195.28 $143,022 - $267,728	-1,371 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$163.48 - $173.61 $224,131 - $238,019	1,371 New	1,371 $231,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Tiedemann Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tiedemann Advisors, LLC with notifications on news.